560
Participants
Start Date
February 28, 2007
Primary Completion Date
December 31, 2016
Study Completion Date
June 30, 2017
Oral Insulin
7.5 mg oral insulin or placebo given before breakfast on a daily basis.
Placebo
Placebo capsule designed to match active drug
Walter and Eliza Hall Institute, Parkville
Columbia University, New York
Childrens Hospital of Pittsburgh, Pittsburgh
San Raffaele Hospital, Milan
University of Miami, Miami
Indiana University-Riley Hospital for Children, Indianapolis
University of Minnesota, Minneapolis
Barbara Davis Center for Childhood Diabetes, Aurora
University of California-San Francisco, San Francisco
Stanford University, Stanford
Benaroya Research Institute, Seattle
Yale University, New Haven
University of Florida, Gainesville
Vanderbilt Eskind Diabetes Clinic, Nashville
University of Texas, Dallas
The Hospital for Sick Children, Toronto
University of Turku, Turku
University of Bristol, Bristol
Collaborators (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
National Center for Research Resources (NCRR)
NIH
American Diabetes Association
OTHER
Juvenile Diabetes Research Foundation
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH